Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Selection Trial of FLASH Versus Conventional Radiotherapy for Participants With Localized Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

NCT07455331 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT07455331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Selection Trial of FLASH Versus Conventional Radiotherapy for Participants With Localized Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 23, 2026
Completion date
December 23, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma (bcc), cutaneous squamous cell carcinoma (cscc)